TrialPath
Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

NCT06959095 · GlaxoSmithKline
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab In Adult Participants With COPD With Type 2 Inflammation
About this study
Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.
Eligibility criteria
Inclusion Criteria: * Participants must be greater than or equal to (\>=) 40 to less than or equal to (\<=) 80 years of age, at the time of signing the informed consent * Elevated blood eosinophil count (BEC). * Moderate to severe COPD with frequent exacerbations, defined as: * A clinically documented history of COPD as defined by the American Thoracic Society/European Respiratory Society for at least 1 year * A post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio of less than (\<) 0.70 and a post- bronchodilator FEV1 \>30 percent (%) and \<= 80% predicted normal values * A well-documented history of at least 2 moderate or 1 severe exacerbation in the 12 months prior to screening * COPD assessment test (CAT) score \>=10 at Visit 1 * Smoking status: Current or former cigarette smokers with a history of cigarette smoking of \>=10 pack-years. * Participants should be on optimized inhaler therapy, defined as inhaled corticosteroid (ICS) plus Long-acting muscarinic receptor antagonist (LAMA) plus Long-acting beta2-adrenergic receptor agonist (LABA) either as multiple inhalers or a single combination inhaler for at least 6 months prior to Screening Visit 1 * Body mass index (BMI) \>=16 kilogram per square meter (kg/m\^2). * Male or eligible female participants Exclusion Criteria: The following subjects are excluded: * Participants with a current or prior physician diagnosis of asthma * Other clinically significant lung disease: The Investigator must judge that COPD is the primary diagnosis accounting for the clinical manifestations of the lung disease * Participants with pneumonia, COPD exacerbation, or lower respiratory tract infection within the 4 weeks prior to Screening Visit 1 * Lung resection: Participants with a history of, or plan for lung volume reduction surgery / endobronchial valve procedure * Pulmonary rehabilitation: Participants in the acute phase of a pulmonary rehabilitation program within 4 weeks prior to Screening Visit 1. * Continuous oxygen: Participants requiring oxygen supplementation for more than 16 hours per day to maintain resting oxygen saturation greater than 88% * Cor pulmonale - resulting in right heart failure, severe pulmonary hypertension * Chronic hypercapnia requiring Non-invasive positive pressure ventilation (NIPPV) use (including Bi-Level Positive Airway Pressure \[BiPAP\] or Continuous Positive Airway Pressure \[CPAP\]) * Unstable cardiovascular disease or arrhythmia. * Parasitic Infection: Participants with a known, pre-existing parasitic infection within 6 months of Screening (Visit 1)
Study design
Enrollment target: 981 participants
Allocation: randomized
Masking: quadruple
Age groups: adult, older_adult
Timeline
Starts: 2025-06-20
Estimated completion: 2029-02-14
Last updated: 2026-10-05
Interventions
Biological: DepemokimabDrug: Placebo
Primary outcomes
  • • Annualized Rate of Moderate/Severe Exacerbations (From Baseline up to Week 104)
Sponsor
GlaxoSmithKline · industry
Contacts & investigators
ContactUS GSK Clinical Trials Call Center · contact · GSKClinicalSupportHD@gsk.com · 877-379-3718
ContactEU GSK Clinical Trials Call Center · contact · GSKClinicalSupportHD@gsk.com · +44 (0) 20 89904466
InvestigatorGSK Clinical Trials · study_director, GlaxoSmithKline
All locations (281)
GSK Investigational SiteRecruiting
Bakersfield, California, United States
GSK Investigational SiteRecruiting
Modesto, California, United States
GSK Investigational SiteRecruiting
Newport Beach, California, United States
GSK Investigational SiteRecruiting
Wilmington, Delaware, United States
GSK Investigational SiteRecruiting
Bradenton, Florida, United States
GSK Investigational SiteRecruiting
Brandon, Florida, United States
GSK Investigational SiteRecruiting
Hialeah, Florida, United States
GSK Investigational SiteRecruiting
Hialeah, Florida, United States
GSK Investigational SiteRecruiting
Loxahatchee Groves, Florida, United States
GSK Investigational SiteRecruiting
Miami, Florida, United States
GSK Investigational SiteRecruiting
Miami, Florida, United States
GSK Investigational SiteRecruiting
Miami Lakes, Florida, United States
GSK Investigational SiteRecruiting
Orange City, Florida, United States
GSK Investigational SiteRecruiting
Palm Springs, Florida, United States
GSK Investigational SiteRecruiting
Palmetto Bay, Florida, United States
GSK Investigational SiteRecruiting
Pensacola, Florida, United States
GSK Investigational SiteRecruiting
Tamarac, Florida, United States
GSK Investigational SiteRecruiting
Tampa, Florida, United States
GSK Investigational SiteRecruiting
The Villages, Florida, United States
GSK Investigational SiteRecruiting
Riverdale, Georgia, United States
GSK Investigational SiteRecruiting
Stonecrest, Georgia, United States
GSK Investigational SiteRecruiting
Chicago, Illinois, United States
GSK Investigational SiteRecruiting
Baltimore, Maryland, United States
GSK Investigational SiteRecruiting
Clarkston, Michigan, United States
GSK Investigational SiteRecruiting
Flint, Michigan, United States
GSK Investigational SiteRecruiting
St Louis, Missouri, United States
GSK Investigational SiteRecruiting
Henderson, Nevada, United States
GSK Investigational SiteRecruiting
Las Vegas, Nevada, United States
GSK Investigational SiteRecruiting
Reno, Nevada, United States
GSK Investigational SiteRecruiting
North Massapequa, New York, United States
GSK Investigational SiteRecruiting
Winston-Salem, North Carolina, United States
GSK Investigational SiteRecruiting
Winston-Salem, North Carolina, United States
GSK Investigational SiteRecruiting
Greenville, South Carolina, United States
GSK Investigational SiteRecruiting
Rock Hill, South Carolina, United States
GSK Investigational SiteRecruiting
Franklin, Tennessee, United States
GSK Investigational SiteRecruiting
Corsicana, Texas, United States
GSK Investigational SiteRecruiting
Dallas, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
McKinney, Texas, United States
GSK Investigational SiteRecruiting
Pearland, Texas, United States
GSK Investigational SiteRecruiting
La Plata, Provincia de Bs AS, Argentina
GSK Investigational SiteRecruiting
Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Ciudad Autonoma de Bueno, Argentina
GSK Investigational SiteRecruiting
Mendoza, Argentina
GSK Investigational SiteRecruiting
Mendoza, Argentina
GSK Investigational SiteRecruiting
Paraná, Argentina
GSK Investigational SiteRecruiting
Rosario, Argentina
GSK Investigational SiteRecruiting
San Juan Bautista, Argentina
GSK Investigational SiteRecruiting
San Miguel de Tucumán, Argentina
GSK Investigational SiteRecruiting
San Miguel de Tucumán, Argentina
GSK Investigational SiteRecruiting
San Miguel de Tucumán, Argentina
GSK Investigational SiteRecruiting
Aalst, Belgium
GSK Investigational SiteRecruiting
Genk, Belgium
GSK Investigational SiteRecruiting
Kortrijk, Belgium
GSK Investigational SiteRecruiting
Liège, Belgium
GSK Investigational SiteRecruiting
Liège, Belgium
GSK Investigational SiteRecruiting
Namur, Belgium
GSK Investigational SiteRecruiting
Sint-Niklaas, Belgium
GSK Investigational SiteRecruiting
Richmond, British Columbia, Canada
GSK Investigational SiteRecruiting
Ajax, Ontario, Canada
GSK Investigational SiteRecruiting
Toronto, Ontario, Canada
GSK Investigational SiteRecruiting
Windsor, Ontario, Canada
GSK Investigational SiteRecruiting
Saint-Charles-Borromée, Quebec, Canada
GSK Investigational SiteRecruiting
Sherbrooke, Quebec, Canada
GSK Investigational SiteRecruiting
Saskatoon, Saskatchewan, Canada
GSK Investigational SiteRecruiting
Curicó, Chile
GSK Investigational SiteRecruiting
Haikou, Hainan, China
GSK Investigational SiteRecruiting
Changsha, Hunan, China
GSK Investigational SiteRecruiting
Chengdu, Sichuan, China
GSK Investigational SiteRecruiting
Beijing, China
GSK Investigational SiteRecruiting
Beijing, China
GSK Investigational SiteRecruiting
Changchun, China
GSK Investigational SiteRecruiting
Changchun, China
GSK Investigational SiteRecruiting
Changsha, China
GSK Investigational SiteRecruiting
Chengdu, China
GSK Investigational SiteRecruiting
Chongqing, China
GSK Investigational SiteRecruiting
Dongguan, China
GSK Investigational SiteRecruiting
Fuyang, China
GSK Investigational SiteRecruiting
Guangzhou, China
GSK Investigational SiteRecruiting
Guangzhou, China
GSK Investigational SiteRecruiting
Guilin, China
GSK Investigational SiteRecruiting
Hangzhou, China
GSK Investigational SiteRecruiting
Hangzhou, China
GSK Investigational SiteRecruiting
Hefei, China
GSK Investigational SiteRecruiting
Hohhot, China
GSK Investigational SiteRecruiting
Hohhot, China
GSK Investigational SiteRecruiting
Huizhou, China
GSK Investigational SiteRecruiting
Huizhou, China
GSK Investigational SiteRecruiting
Jiangmen, China
GSK Investigational SiteRecruiting
Jiangmen, China
GSK Investigational SiteRecruiting
Jiangsu, China
GSK Investigational SiteRecruiting
Jiangxi, China
GSK Investigational SiteRecruiting
Jinan, China
GSK Investigational SiteRecruiting
Kunming, China
GSK Investigational SiteRecruiting
Kunming, China
GSK Investigational SiteRecruiting
Lianyungang, China
GSK Investigational SiteRecruiting
Liuzhou, China
GSK Investigational SiteRecruiting
Meizhou, China
GSK Investigational SiteRecruiting
Mianyang, China
GSK Investigational SiteRecruiting
Nanchang, China
GSK Investigational SiteRecruiting
Nanchang, China
GSK Investigational SiteRecruiting
Qingdao, China
GSK Investigational SiteRecruiting
Qingyuan, China
GSK Investigational SiteRecruiting
Qinhuangdao, China
GSK Investigational SiteRecruiting
Shanghai, China
GSK Investigational SiteRecruiting
Shanghai, China
GSK Investigational SiteRecruiting
Shanghai, China
GSK Investigational SiteRecruiting
Shanghai, China
GSK Investigational SiteRecruiting
Suzhou, China
GSK Investigational SiteRecruiting
Taiyuan, China
GSK Investigational SiteRecruiting
Taizhou, China
GSK Investigational SiteRecruiting
Ürümqi, China
GSK Investigational SiteRecruiting
Weifang, China
GSK Investigational SiteRecruiting
Wenzhou, China
GSK Investigational SiteRecruiting
Wuhan, China
GSK Investigational SiteRecruiting
Wuxi, China
GSK Investigational SiteRecruiting
Xi'an, China
GSK Investigational SiteRecruiting
Xiamen, China
GSK Investigational SiteRecruiting
Xiamen, China
GSK Investigational SiteRecruiting
Yinchuan, China
GSK Investigational SiteRecruiting
Zhanjiang, China
GSK Investigational SiteRecruiting
Zhengzhou, China
GSK Investigational SiteRecruiting
Zigong, China
GSK Investigational SiteRecruiting
Split, Croatia
GSK Investigational SiteRecruiting
Zagreb, Croatia
GSK Investigational SiteRecruiting
Roskilde, Region Sjælland, Denmark
GSK Investigational SiteRecruiting
Aalborg, Denmark
GSK Investigational SiteRecruiting
Hvidovre, Denmark
GSK Investigational SiteRecruiting
Saint-Quentin, Aisne, France
GSK Investigational SiteRecruiting
Marseille, Bouches-du-Rhône, France
GSK Investigational SiteRecruiting
Amiens, France
GSK Investigational SiteRecruiting
Blois, France
GSK Investigational SiteRecruiting
Caen, France
GSK Investigational SiteRecruiting
La Tronche, France
GSK Investigational SiteRecruiting
Lyon, France
GSK Investigational SiteRecruiting
Nice, France
GSK Investigational SiteRecruiting
Pessac, France
GSK Investigational SiteRecruiting
Toulouse, France
GSK Investigational SiteRecruiting
Villeurbanne, France
GSK Investigational SiteRecruiting
Löwenstein, Baden-Wurttemberg, Germany
GSK Investigational SiteRecruiting
Donaustauf, Bavaria, Germany
GSK Investigational SiteRecruiting
Peine, Lower Saxony, Germany
GSK Investigational SiteRecruiting
Essen, North Rhine-Westphalia, Germany
GSK Investigational SiteRecruiting
Ahrensburg, Germany
GSK Investigational SiteRecruiting
Berlin, Germany
GSK Investigational SiteRecruiting
Berlin, Germany
GSK Investigational SiteRecruiting
Bonn, Germany
GSK Investigational SiteRecruiting
Frankfurt am Main, Germany
GSK Investigational SiteRecruiting
Frankfurt am Main, Germany
GSK Investigational SiteRecruiting
Giessen, Germany
GSK Investigational SiteRecruiting
Kiel, Germany
GSK Investigational SiteRecruiting
Mainz, Germany
GSK Investigational SiteRecruiting
München, Germany
GSK Investigational SiteRecruiting
Wiesbaden, Germany
GSK Investigational SiteRecruiting
Wuppertal, Germany
GSK Investigational SiteRecruiting
Würzburg, Germany
GSK Investigational SiteRecruiting
Budapest, Hungary
GSK Investigational SiteRecruiting
Budapest, Hungary
GSK Investigational SiteRecruiting
Pécs, Hungary
GSK Investigational SiteRecruiting
Törökbálint, Hungary
GSK Investigational SiteRecruiting
Dublin, Co. Dublin, Ireland
GSK Investigational SiteRecruiting
Cork, Ireland
GSK Investigational SiteRecruiting
Drogheda, Ireland
GSK Investigational SiteRecruiting
Dublin, Ireland
GSK Investigational SiteRecruiting
Galway, Ireland
GSK Investigational SiteRecruiting
Mullingar, Ireland
GSK Investigational SiteRecruiting
Kitakyushu-shi, Fukuoka, Japan
GSK Investigational SiteRecruiting
Chiba, Japan
GSK Investigational SiteRecruiting
Chiba, Japan
GSK Investigational SiteRecruiting
Chiba, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukushima, Japan
GSK Investigational SiteRecruiting
Gifu, Japan
GSK Investigational SiteRecruiting
Hokkaido, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Ibaraki, Japan
GSK Investigational SiteRecruiting
Ishikawa, Japan
GSK Investigational SiteRecruiting
Kagawa, Japan
GSK Investigational SiteRecruiting
Kanagawa, Japan
GSK Investigational SiteRecruiting
Kanagawa, Japan
GSK Investigational SiteRecruiting
Kanagawa, Japan
GSK Investigational SiteRecruiting
Kyoto, Japan
GSK Investigational SiteRecruiting
Mie, Japan
GSK Investigational SiteRecruiting
Mie, Japan
GSK Investigational SiteRecruiting
Nankoku-shi, Japan
GSK Investigational SiteRecruiting
Niigata, Japan
GSK Investigational SiteRecruiting
Niigata, Japan
GSK Investigational SiteRecruiting
Okayama, Japan
GSK Investigational SiteRecruiting
Omuta Shi, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Yamaguchi, Japan
GSK Investigational SiteRecruiting
Yokohama, Japan
GSK Investigational SiteRecruiting
Zutphen, Gelderland, Netherlands
GSK Investigational SiteRecruiting
Breda, North Brabant, Netherlands
GSK Investigational SiteRecruiting
Zwolle, Overijssel, Netherlands
GSK Investigational SiteRecruiting
Deventer, Netherlands
GSK Investigational SiteRecruiting
Enschede, Netherlands
GSK Investigational SiteRecruiting
Harderwijk, Netherlands
GSK Investigational SiteRecruiting
Hoofddorp, Netherlands
GSK Investigational SiteRecruiting
Nijmegen, Netherlands
GSK Investigational SiteRecruiting
Lørenskog, Akershus, Norway
GSK Investigational SiteRecruiting
Poznan, Greater Poland Voivodeship, Poland
GSK Investigational SiteRecruiting
Katowice, Silesian Voivodeship, Poland
GSK Investigational SiteRecruiting
Bialystok, Poland
GSK Investigational SiteRecruiting
Bydgoszcz, Poland
GSK Investigational SiteRecruiting
Krakow, Poland
GSK Investigational SiteRecruiting
Poznan, Poland
GSK Investigational SiteRecruiting
Rzeszów, Poland
GSK Investigational SiteRecruiting
Rzeszów, Poland
GSK Investigational SiteRecruiting
Wroclaw, Poland
GSK Investigational SiteRecruiting
Loures, Lisbon District, Portugal
GSK Investigational SiteRecruiting
Senhora da Hora, Porto District, Portugal
GSK Investigational SiteRecruiting
Almada, Setúbal District, Portugal
GSK Investigational SiteRecruiting
Guarda, Portugal
GSK Investigational SiteRecruiting
Lisbon, Portugal
GSK Investigational SiteRecruiting
Lisbon, Portugal
GSK Investigational SiteRecruiting
Lisbon, Portugal
GSK Investigational SiteRecruiting
Setúbal, Portugal
GSK Investigational SiteRecruiting
Vila Nova de Gaia, Portugal
GSK Investigational SiteRecruiting
Košice, Slovakia
GSK Investigational SiteRecruiting
Spišská Nová Ves, Slovakia
GSK Investigational SiteRecruiting
Pozuelo de Alarcón, Madrid, Spain
GSK Investigational SiteRecruiting
Marbella, Málaga, Spain
GSK Investigational SiteRecruiting
Alzira, Spain
GSK Investigational SiteRecruiting
Barcelona, Spain
GSK Investigational SiteRecruiting
Benalmádena, Spain
GSK Investigational SiteRecruiting
Ferrol, Spain
GSK Investigational SiteRecruiting
GaldakaoVizcaya, Spain
GSK Investigational SiteRecruiting
Madrid, Spain
GSK Investigational SiteRecruiting
Madrid, Spain
GSK Investigational SiteRecruiting
Marbella, Spain
GSK Investigational SiteRecruiting
Málaga, Spain
GSK Investigational SiteRecruiting
Málaga, Spain
GSK Investigational SiteRecruiting
Palma de Mallorca, Spain
GSK Investigational SiteRecruiting
Santander, Spain
GSK Investigational SiteRecruiting
Seville, Spain
GSK Investigational SiteRecruiting
Zaragoza, Spain
GSK Investigational SiteRecruiting
Lund, Sweden
GSK Investigational SiteRecruiting
Stockholm, Sweden
GSK Investigational SiteRecruiting
Stockholm, Sweden
GSK Investigational SiteRecruiting
Aarau, Switzerland
GSK Investigational SiteRecruiting
Zurich, Switzerland
GSK Investigational SiteRecruiting
Changhua, Taiwan
GSK Investigational SiteRecruiting
Kaohsiung City, Taiwan
GSK Investigational SiteRecruiting
Taichung, Taiwan
GSK Investigational SiteRecruiting
Taichung, Taiwan
GSK Investigational SiteRecruiting
Taipei, Taiwan
GSK Investigational SiteRecruiting
Taipei, Taiwan
GSK Investigational SiteRecruiting
Taipei, Taiwan
GSK Investigational SiteRecruiting
Izmir, Balcova, Turkey (Türkiye)
GSK Investigational SiteRecruiting
Antalya, Konyaaltı, Turkey (Türkiye)
GSK Investigational SiteRecruiting
Denizli, Pamukkale, Turkey (Türkiye)
GSK Investigational SiteRecruiting
Çanakkale, Turkey (Türkiye)
GSK Investigational SiteRecruiting
İzmit, Turkey (Türkiye)